Brind.
  1. Bio-Techne is facing scrutiny regarding its market performance and the growth of Protein Sciences, questioned by a UBS analyst.
  2. Protein Sciences accounts for 72% of net sales for Bio-Techne.

The business unit of Protein Sciences is generating cash flows.

1 report, 1 independent Updated Jul 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

The business unit of Protein Sciences is generating cash flows.

Who's involved

What this event is mainly about
Bio-TechneProtein Sciences

Keep exploring

Part of

Protein Sciences accounts for 72% of net sales for Bio-Techne. All 1 developments

Within Bio-Techne is facing scrutiny regarding its market performance and the growth of Protein Sciences, questioned by a UBS analyst.

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • Insider MonkeyBio-Techne Corporation (TECH): A Bull Case Theory We came across a bullish thesis on Bio-Techne Corporation on Stock Analysis Compilation’s Substack. In this article, we will summarize the bulls’ the